'Eart failure treatment' diaporamas de présentation

Pisa

726 views • 53 slides

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial. Main results. www.shift-study.com. Swedberg K, et al. Lancet . 2010;376(9744):875-885. Primary composite endpoint (CV death or hospital admission for worsening HF). Cumulative frequency (%). 40.

222 views • 11 slides

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial. Influence of background treatment with mineralocorticoid receptor antagonists on ivabradine's effects in patients with chronic heart failure.

269 views • 9 slides

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial. Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure/left ventricular dysfunction in the SHIFT trial. Borer JS, et al. Am J Cardiol . 2013. 2014;113(3):497-503.

203 views • 3 slides

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial. Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT study. www.shift-study.com. Tavazzi L, et al. Eur J Heart Fail. 2013;15(11):1296-1303.

185 views • 3 slides

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial. Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients. Reil JC, et al. J Am Coll Cardiol . 2013 Nov 19;62(21):1977-1985. www.shift-study.com.

147 views • 3 slides

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial. Clinical profiles and outcomes of patients with chronic heart failure and chronic obstructive pulmonary disease: efficacy and safety of ivabradine . A SHIFT study analysis.

170 views • 2 slides